No recent analyst price targets found for BOVNF.
Latest News for BOVNF
BioInvent International AB (publ) (BOVNF) Q4 2025 Earnings Call Transcript
BioInvent International AB (publ) (BOVNF) Q4 2025 Earnings Call Transcript
BioInvent International AB: Year-End Report January 1 - December 31, 2025
LUND, SE / ACCESS Newswire / February 26, 2026 / BioInvent International (STO:BINV) - "During 2025 we sharpened our clinical focus and resource allocation to accelerate our most advanced assets, BI-1808 (anti-TNFR2) and BI-1206 (anti-FcγRIIB), while pausing earlier programs to maximize the probability of success and near-term value creation."- Martin Welschof, CEO BioInvent.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BOVNF.
Senate Trading
No Senate trades found for BOVNF.
U.S. House Trading
No House trades found for BOVNF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.